glp-1 prader willi Weight Loss of Over 100 lbs in a Patient of Prader-Willi Syndrome Treated With Glucagon-Like Peptide-1 (GLP-1) Agonists Can Semaglutide Help Prader-Willi Syndrome?

doi: 10.1111/andr.12913

Typical semaglutide escalation follows a pattern: 0.25 mg for weeks 1 through 4, then 0.5 mg for weeks 5 through 8, then gradual increases toward the target dose of 1.0 to 2.4 mg depending on response and tolerance

A metaanalysis showed that GLP1 RAs may resolve NAFLD (Ghosal et al., 2021) and recently, a phase 2 study showed that the GLP1 RA semaglutide was able to provide significant resolution of NASH (Newsome et al., 2021)

FIGURE 8 Statements Data availability statement The datasets presented in this study can be found in online repositories

GLP-1 medications are the center of weight loss conversations right now, but they can be expensive and complicated to get your insurance to cover